BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38411285)

  • 1. Scoring system for diagnosis and pretreatment risk assessment of neuroblastoma using urinary biomarker combinations.
    Amano H; Uchida H; Harada K; Narita A; Fumino S; Yamada Y; Kumano S; Abe M; Ishigaki T; Sakairi M; Shirota C; Tainaka T; Sumida W; Yokota K; Makita S; Karakawa S; Mitani Y; Matsumoto S; Tomioka Y; Muramatsu H; Nishio N; Osawa T; Taguri M; Koh K; Tajiri T; Kato M; Matsumoto K; Takahashi Y; Hinoki A
    Cancer Sci; 2024 May; 115(5):1634-1645. PubMed ID: 38411285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical validation of urine 3-methoxytyramine as a biomarker of neuroblastoma and comparison with other catecholamine-related biomarkers.
    Lam L; Woollard GA; Teague L; Davidson JS
    Ann Clin Biochem; 2017 Mar; 54(2):264-272. PubMed ID: 27235704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising urinary catecholamine metabolite diagnostics for neuroblastoma.
    Matser YAH; Verly IRN; van der Ham M; de Sain-van der Velden MGM; Verhoeven-Duif NM; Ash S; Cangemi G; Barco S; Popovic MB; van Kuilenburg ABP; Tytgat GAM;
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30289. PubMed ID: 37010353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylated catecholamine metabolites for diagnosis of neuroblastoma.
    Candito M; Thyss A; Albertini M; Deville A; Politano S; Mariani R; Chambon P
    Med Pediatr Oncol; 1992; 20(3):215-20. PubMed ID: 1574031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamines profiles at diagnosis: Increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients.
    Verly IR; van Kuilenburg AB; Abeling NG; Goorden SM; Fiocco M; Vaz FM; van Noesel MM; Zwaan CM; Kaspers GL; Merks JH; Caron HN; Tytgat GA
    Eur J Cancer; 2017 Feb; 72():235-243. PubMed ID: 28061374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial urinary catecholamine metabolite concentrations and prognosis in neuroblastoma.
    Laug WE; Siegel SE; Shaw KN; Landing B; Baptista J; Gutenstein M
    Pediatrics; 1978 Jul; 62(1):77-83. PubMed ID: 683787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical validation and clinical application of urinary vanillylmandelic acid and homovanillic acid by LC-MS/MS for diagnosis of neuroblastoma.
    Shen Y; Li H; Lu J; Luo X; Guan Q; Cheng L
    Biomed Chromatogr; 2019 Jun; 33(6):e4484. PubMed ID: 30632178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated versus "free" acidic metabolites of catecholamines in random urine samples: significance for the diagnosis of neuroblastoma.
    Tuchman M; Stoeckeler JS
    Pediatr Res; 1988 Jun; 23(6):576-9. PubMed ID: 3393388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of random urinary homovanillic acid and vanillylmandelic acid levels in the diagnosis and management of patients with neuroblastoma: comparison with 24-hour urine collections.
    Tuchman M; Morris CL; Ramnaraine ML; Bowers LD; Krivit W
    Pediatrics; 1985 Feb; 75(2):324-8. PubMed ID: 3969335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrine.
    Peitzsch M; Butch ER; Lovorn E; Mangelis A; Furman WL; Santana VM; Hero B; Berthold F; Shulkin BL; Huebner A; Eisenhofer G
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28081. PubMed ID: 31724812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a new biochemical test to diagnose and monitor neuroblastoma in Vietnam: homovanillic and vanillylmandelic acid by gas chromatography-mass spectrometry.
    Tran MT; Baglin J; Tran TT; Hoang KT; Phung LT; Read A; Greaves RF
    Clin Biochem; 2014 Feb; 47(3):206-15. PubMed ID: 24296288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.
    Strenger V; Kerbl R; Dornbusch HJ; Ladenstein R; Ambros PF; Ambros IM; Urban C
    Pediatr Blood Cancer; 2007 May; 48(5):504-9. PubMed ID: 16732582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of Neuroblastoma Markers Homovanillic Acid (HVA) and Vanillylmandelic Acid (VMA) in Urine by Gas Chromatography-Mass Spectrometry (GC/MS).
    Beals M; Ramoo B; Clinton Frazee C; Garg U
    Methods Mol Biol; 2022; 2546():185-194. PubMed ID: 36127589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new urinary mass screening system for neuroblastoma in infancy by use of monoclonal antibodies against VMA and HVA.
    Yokomori K; Hori T; Tsuchida Y; Kuroda M; Yoshioka M
    J Pediatr Surg; 1989 Apr; 24(4):391-4. PubMed ID: 2659761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
    Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
    Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sensitivity and specificity of the determination of urinary catecholamines and their acid metabolites in the diagnosis of neuroblastoma in children].
    Horsmans Y; Desager JP; Harvengt C
    Bull Cancer; 1990; 77(10):985-9. PubMed ID: 2249018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of vanillylmandelic acid and homovanillic acid by UPLC-MS/MS in serum for diagnostic testing for neuroblastoma.
    Sadilkova K; Dugaw K; Benjamin D; Jack RM
    Clin Chim Acta; 2013 Sep; 424():253-7. PubMed ID: 23830883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related medical decision limits for urinary free (unconjugated) metadrenalines, catecholamines and metabolites in random urine specimens from children.
    Davidson DF; Hammond PJ; Murphy D; Carachi R
    Ann Clin Biochem; 2011 Jul; 48(Pt 4):358-66. PubMed ID: 21670092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass screening for neuroblastoma in Miyagi Prefecture.
    Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
    Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
    Sawada T
    Pediatr Hematol Oncol; 1997; 14(4):291-3. PubMed ID: 9211532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.